aListed below are the products that have had a report on adverse events presented to the Pediatric Advisory Committee(PAC). Click on the drug name to go to the meeting materials. Learn about Pepcid (Famotidine) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Learn about Prilosec (Omeprazole) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Table 2: Recommended Dosage Regimen of Prilosec in Pediatric Patients by Indication * The efficacy of Prilosec used for longer than 8 weeks in patients with EE has not been established. How to use Synthroid. Read the Patient Information Leaflet if available from your pharmacist before you start taking levothyroxine and each time you get a refill. Losartan (Cozaar) is a drug prescribed to treat high blood pressure, reduce the risk of stroke in those with hypertension, type 2 diabetes, diabetic neuropathy and kidney disease. Side effects include chest pain, diarrhea, dizziness, fatigue, nasal congestion, UTIs, and weakness. Losartan belongs to the Statin drug class. Diazepam (Valium, Diastat, Acudial, Diastat Pediatric, Diazepam Intensol) is a drug used for the short-term relief of symptoms related to anxiety disorders; and symptoms that result from alcohol withdrawal. Common side effects are headache, nausea, and vomiting. Valium has many drug interactions. Pregnancy and breastfeeding information also is. NEXIUM has multiple pediatric indications. Short-term treatment (4-8 weeks) of heartburn and other symptoms associated with GERD, with or without erosive esophagitis, in pediatric and adolescent patients 1 year of age and older Doctors give trusted answers on uses, effects, side-effects, and cautions: Dr. Dosanjh on zantac pediatric dosage: The dose depends on indication, child's age and weight. In general for reflux 0.1-0.2 mg/kg orally or IV for children 6 years old is dose. For age 6-14 years old generally 2.5 to 5 mg orally or IV prescribed. Higher doses up to 1. Pediatric Use: The safety and effectiveness of ZANTAC have been established in the age-group of 1 month to 16 years. There is insufficient information about the pharmacokinetics of ZANTAC in neonatal patients (aged younger than 1 month) to make dosing recommendations.